Who
Barry P. Flannelly
Director
Company insider
Files Form 4 as: Director, Protara Therapeutics; EVP & General Manager US, Incyte; Director, Genomic Health.
In numbers
- Trades disclosed
- 154
- Buys
- 0
- Sells
- 26
- Bought
- $0
- Sold
- $16.2M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 11 Aug 2014
- Last trade
- 15 Jun 2026
- Last filed
- 16 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 16 Jun 2026 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,000 at $0.00 | filing |
| 15 Jun 2026filed 16 Jun 2026 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,000 at $0.00 | filing |
| 16 Jul 2025filed 17 Jul 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $92K1,340 at $68.36 | filing |
| 15 Jul 2025filed 16 Jul 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $83K1,192 at $69.86 | filing |
| 15 Jul 2025filed 16 Jul 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $78K1,141 at $68.25 | filing |
| 14 Jul 2025filed 16 Jul 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $65K922 at $69.98 | filing |
| 3 Jul 2025filed 7 Jul 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $743K10,903 at $68.15 | filing |
| 2 Jul 2025filed 7 Jul 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $617K9,055 at $68.17 | filing |
| 12 Jun 2025filed 13 Jun 2025 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 1 Apr 2025filed 3 Apr 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code A | —11,159 at $0.00 | filing |
| 1 Apr 2025filed 3 Apr 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code A | —14,976 at $0.00 | filing |
| 14 Mar 2025filed 18 Mar 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $31K461 at $67.85 | filing |
| 14 Mar 2025filed 18 Mar 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $14K199 at $67.88 | filing |
| 14 Mar 2025filed 18 Mar 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $1.3M19,147 at $67.68 | filing |
| 17 Jan 2025filed 22 Jan 2025 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —20,144 at $0.00 | filing |
| 15 Jan 2025filed 17 Jan 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $229K3,158 at $72.46 | filing |
| 9 Dec 2024filed 11 Dec 2024 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $109K1,510 at $72.11 | filing |
| 6 Nov 2024filed 8 Nov 2024 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,424 at $0.00 | filing |
| 6 Nov 2024filed 8 Nov 2024 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code M | —2,256 at $0.00 | filing |
| 6 Nov 2024filed 8 Nov 2024 | INCY IncyteLife-science tools | SEC FORM 4 Code M | $103K1,424 at $72.27 | filing |
News
No headline names them, or the companies they trade most, lately.